Introducing Innovax®-ND-ILT
Introducing Innovax®-ND-ILT, the latest addition to our dual construct HVT vaccine range.
Administered as a single in-ovo or subcutaneous injection, Innovax-ND-ILT provides effective 3-in-1 protection against Marek’s Disease (MD), Newcastle Disease (ND) and Infectious Laryngotracheitis (ILT).
Learn more about Innovax ND-ILT and its benefits below:
Convenient 3-IN-1 Protection
Innovax-ND-ILT provides protection against Newcastle Disease, Infectious Laryngotracheitis and Marek's Disease from a single in-ovo or subcutaneous injection, helping to reduce the number of vaccinations required on farm.
For more product information:
Excellent Safety Profile
In registration trials no adverse reactions were observed following in-ovo and subcutaneous vaccination at 10 x the field dose with no impact on hatchability or average weight gain.1
Have a question to ask?
Long Lasting Disease Prevention
Innovax-ND-ILT provides 62 week duration of immunity for Newcastle Disease and Infectious Laryngotracheitis, and the entire risk period for Marek's Disease.
For more information on Innovax-ND-ILT and it's indication for use:
No Reversion To Virulence
Innovax-ND-ILT contains only fragments of ILT and ND viruses, safety trials demonstrated no horizontal spread of vaccine virus or reversion to virulence.1
Have a question to ask?
Proven Performance
Challenge studies have demonstrated that Innovax-ND-ILT provides excellent protection against all three pathogens following single in-ovo or subcutaneous vaccination.1
For more information on Innovax-ND-ILT:
References
Reference 1. A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek’s diseases. Gergen et al. Avian Pathology 2019, VOL. 48, NO. 1, 45-56.
Innovax®-ND-ILT contains cell-associated live recombinant turkey herpesvirus (strain HVT/NDV/ILT), expressing the fusion protein of Newcastle disease virus and the glycoproteins gD and gI of infectious laryngotracheitis virus: 103.3 – 104.3 PFU. POM-V. Nobilis® Rismavac contains live cell associated Marek’s disease virus strain CVI988 ≥ 3.0 log10 TCID50. POM-VPS.
Further information is available from the SPC, datasheet or package leaflet. MSD Animal Health UK Ltd. Registered office Walton Manor, Walton, Milton Keynes MK7 7AJ, UK. Registered in England & Wales no. 946942. Advice should be sought from the medicine prescriber.
Use Medicines Responsibly.
